These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3705994

  • 1. Schizophrenic relapse after drug withdrawal is predictable.
    Dencker SJ, Malm U, Lepp M.
    Acta Psychiatr Scand; 1986 Feb; 73(2):181-5. PubMed ID: 3705994
    [Abstract] [Full Text] [Related]

  • 2. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B, Palmstierna T.
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Flupenthixol versus haloperidol in acute psychosis.
    Parent M, Toussaint C.
    Pharmatherapeutica; 1983 Oct; 3(5):354-64. PubMed ID: 6844372
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The positive and negative symptoms of schizophrenia: patterns of response to depot neuroleptic treatment.
    Martyns-Yellowe IS.
    West Afr J Med; 1994 Oct; 13(4):200-3. PubMed ID: 7756183
    [Abstract] [Full Text] [Related]

  • 12. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S, Spechtmeyer H.
    Int Pharmacopsychiatry; 1982 Oct; 17(3):170-84. PubMed ID: 7141812
    [Abstract] [Full Text] [Related]

  • 13. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS, Delva NJ, Beninger RJ.
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [Abstract] [Full Text] [Related]

  • 14. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
    Carney MW.
    Pharmatherapeutica; 1984 Jun; 4(1):57-63. PubMed ID: 6150493
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
    Viswanathan R, Rajhkowa S.
    Pharmatherapeutica; 1982 Jun; 3(2):93-9. PubMed ID: 7100227
    [Abstract] [Full Text] [Related]

  • 20. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
    Dencker SJ, Malm U, Jørgensen A, Overø KF.
    Acta Psychiatr Scand Suppl; 1980 Jun; 279():55-63. PubMed ID: 6931473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.